Search for: "Merck & Co, Inc. "
Results 621 - 640
of 664
Sorted by Relevance
|
Sort by Date
17 Jun 2018, 11:55 pm
Merck and Co., Inc., 110 Nev. 762, 878 P.2d 948 (1994) (Public policy demands that the burden of accidental injuries caused by products intended for consumption be placed upon those that market them and be treated as a cost of production against which liability insurance can be obtained). [read post]
8 Jan 2010, 12:22 am
Supp. 2d 138, 141 (D.D.C. 2008) (citing Merck & Co. v. [read post]
25 Nov 2011, 5:00 am
Merck & Co., 949 A.2d 223, 272 (N.J. [read post]
31 Aug 2014, 12:49 pm
(Pix (c) Larry Catá Backer 2014) Since 2010, I have been posting on the development of a new course I have been developing for our first year law school students, "Elements of Law. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
15 Dec 2014, 7:25 am
The conference, co-chaired by its architects Neil J. [read post]
30 Apr 2018, 2:31 pm
But Phillips and McCauley had a falling-out, and Phillips started posting allegations that McCauley was actually soft on the anti-vaccination movement and was actually "shillin for Merck"; part of his rhetoric was that anti-vaccination people had to save Ella from McCauley, who wasn't adequately protecting her from the evils of vaccines. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
9 May 2008, 10:30 pm
: (Spicy IP), India: Merck vs Roche: towards differential pricing: (Spicy IP), India/Philippines: Access to drugs: The India/Philippines solution? [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
26 Apr 2007, 9:28 am
The question whether the fact that a parallel importer:- fails to affix the trade mark to the new exterior carton (‘de-branding'), or- applies either his own logo or house-style or get-up or a get-up used for a number of different products (‘co-branding'), or- positions the addi [read post]
5 Jan 2010, 11:44 pm
Basic Holding, Inc., 581 F.3d 1317, 1332 (Fed. [read post]
28 Apr 2024, 11:33 am
There was a good bit of irony in Egilman’s reaching out to me to help him prepare for my deposition of him in a silicone gel breast implant case. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
11 Sep 2019, 1:00 pm
The specific DP IV inhibitor sitagliptin as such, however, is not identified in Royalty Pharma’s basic patent as it was developed only after the filing date of the patent (and gave rise to a distinct patent filed by Merck & Co., Inc.). [read post]
21 Mar 2007, 1:05 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
21 Mar 2007, 1:05 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
16 Apr 2012, 1:37 pm
Co., 2010 DNH 131, 2010 U.S. [read post]
7 Jun 2007, 10:52 am
Merck & Co., 961 F. [read post]
